Clinical Trials on Advanced Cervical Cancer in Singapore

Total 644 results

National University Hospital, Singapore

Unknown

Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer

Locally Advanced Cervical Cancer

Singapore
National University Hospital, Singapore

Unknown

The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer

Cancer (Advanced Stage)

Singapore
National University Hospital, Singapore

Recruiting

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

Advanced Refractory Solid Tumors | Advanced Triple Negative Breast Cancers | Metastatic Triple Negative Breast Cancers

Singapore
SingHealth Polyclinics

Completed

Increasing the Uptake of Advanced Directives in SingHealth Polyclinics

Advanced Medical Directive, a Legal Document Signed in Advance to State Healthcare Preferences

Singapore
Hoffmann-La Roche

Terminated

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers

Korea, Republic of, France, Spain, Belgium, United Kingdom, Singapore, Israel, Russian Federation, Taiwan, Switzerland, Turkey, United States, New Zealand, Poland, Germany
National Cancer Centre, Singapore

Recruiting

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Cervix Cancer | Image, Body

Singapore
National University Hospital, Singapore

Recruiting

Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions

Cervical Cancer

Singapore
Duke-NUS Graduate Medical School
National University Hospital, Singapore; National Cancer Centre, Singapore

Unknown

Survival Expectations and Hope Among Cancer Patients at End-of-Life (SHAPE)

Advanced Cancer

Singapore
National University Hospital, Singapore
Adagene Inc

Recruiting

A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer

Advanced Solid Tumor | HER2-negative Breast Cancer

Singapore
National Cancer Centre, Singapore
Singapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaborators

Recruiting

Breast Cancer Exercise Intervention Study (BREXINT)

Locally Advanced Breast Cancer | Early-stage Breast Cancer

Singapore
National Cancer Centre, Singapore
MSD Pharma (Singapore) Pte Ltd

Recruiting

Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole (LaPemERLA)

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Singapore
Novartis Pharmaceuticals

Recruiting

Ribociclib (LEE011) Rollover Study for Continued Access

Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies

Spain, Taiwan, United States, Singapore, France
National University Hospital, Singapore
Merck Sharp & Dohme LLC; Adagene Inc

Recruiting

Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer (ComPACT)

Triple Negative Breast Cancer | Advanced Solid Tumor

Singapore
National Cancer Centre, Singapore

Completed

A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

HER 2 Positive Advanced Gastric Cancer

Singapore
National University Hospital, Singapore

Completed

Aggressiveness of Care at the End of Life in Cancer Patients

Advanced Cancer

Singapore
National University Hospital, Singapore

Unknown

A Clinical Pharmacodynamic and Pharmacogenetic Study of OPB-51602 in Patients With Advanced Solid Tumours

Advanced Solid Tumors

Singapore
National University Hospital, Singapore

Completed

A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Advanced Malignancy

Singapore
National University Hospital, Singapore
INTRA-IMMUSG PRIVATE LIMITED

Unknown

A First-in-Human Study of PRL3-ZUMAB

Advanced Solid Tumors

Singapore
Zeria Pharmaceutical

Completed

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Cervical Cancer

Japan, Korea, Republic of, Malaysia, Singapore, Taiwan, Thailand, Vietnam
National Cancer Centre, Singapore
Duke-NUS Graduate Medical School

Completed

Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer (EQUIP)

Advanced Lung Cancer

Singapore
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore
Singapore General Hospital
Pfizer

Completed

Pregabalin and Radicular Pain Study (PARPS) (PARPS)

Cervical Spondylosis | Cervical Spondylotic Myelopathy | Cervical Spondylotic Radiculopathy

Singapore
National Cancer Centre, Singapore
INTRA-IMMUSG PRIVATE LIMITED

Recruiting

Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors

Hepatocellular Carcinoma | Gastric Cancer | Advanced Solid Tumor

Singapore
National University Hospital, Singapore

Recruiting

A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies

Metastatic Solid Malignancies | Advance Solid Malignancies

Singapore
National University Hospital, Singapore

Unknown

Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma

Advanced Glaucoma | Refractory Glaucoma

Singapore
National University Hospital, Singapore

Unknown

Imaging Ahmed Glaucoma Tubes With a Pericardial Graft and Tissue Glue or Partial-Thickness Scleral Flap and Sutures

Advanced Glaucoma | Failed Trabeculectomies

Singapore
National Cancer Centre, Singapore
Singapore Translational Cancer Consortium; Genome Institute of Singapore; Cancer...

Recruiting

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Advanced Solid Tumours

Singapore
Tan Tock Seng Hospital

Recruiting

HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial

Advanced Cancer | Hyperactive Delirium | Olanzapine | Haloperidol | End-stage Organ Disease

Singapore
National Cancer Institute (NCI)

Completed

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular Carcinoma

United States, Singapore
Bristol-Myers Squibb

Withdrawn

Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers

Advanced Solid Tumors

Australia, Singapore
Duke-NUS Graduate Medical School

Unknown

Panel Study Investigating Status of Cognitively Impaired Elderly in Singapore (PISCES)

Advanced Dementia

Singapore
EDDC (Experimental Drug Development Centre), A*STAR...
Parexel

Recruiting

A Study of EBC-129 in Advanced Solid Tumours

Advanced Solid Tumours

United States, Singapore
GOG Foundation
National Cancer Institute (NCI)

Completed

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IIA Cervical Cancer AJCC v7 | Stage IIB Cervical Cancer AJCC v6 and v7 | Stage IIIB Cervical Cancer AJCC v6 and v7 | Stage IVA Cervical Cancer AJCC v6 and v7 | Stage IB Cervical...

United States, Canada, Saudi Arabia, China, Singapore
MiRXES Pte Ltd

Recruiting

Project CADENCE (CAncer Detected Early caN be CurEd) (CADENCE)

Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver Cancer

Singapore
National University Hospital, Singapore
Tan Tock Seng Hospital

Unknown

Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer

Rectal Cancers.

Singapore
National University Hospital, Singapore

Recruiting

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Advanced Hepatocellular Carcinoma

Singapore
Bayer

Completed

Study of BAY1834942 in Patients With Solid Tumors

Advanced CEACAM6-expressing Solid Tumors

United States, Singapore, Canada
CytoMed Therapeutics Pte Ltd
National University Hospital, Singapore

Not yet recruiting

Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)

Cancer | Malignancy | Relapsed Cancer | Refractory Cancer

Singapore
National University Hospital, Singapore

Unknown

Phase 1b of ASLAN001 (Varlitinib) in Patients With Advanced/ Metastatic Hepatocellular Carcinoma (HCC)

Advanced/ Metastatic Hepatocellular Carcinoma

Singapore
AstraZeneca

Active, not recruiting

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Cervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 Positive

United States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
Novartis Pharmaceuticals

Terminated

Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers

Advanced or Metastatic ER+ Breast Cancer

United States, France, Germany, Singapore, Italy, Japan, Belgium
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer

Cancer of the Uterine Cervix

United States, Singapore, Australia, New Zealand, India
Yisheng Biopharma (Singapore) Pte. Ltd.

Completed

Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors

Cancer

Singapore
National University Hospital, Singapore

Unknown

Familial Cancer Registry and DNA Bank

Cancer

Singapore
National University Hospital, Singapore

Unknown

Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

Cancer

Singapore
National University Hospital, Singapore

Completed

Pyruvate Kinase Isoform M2 (PKM2) as a Possible Biomarker for Cancer

Cancer

Singapore
Duke-NUS Graduate Medical School

Recruiting

Marital Satisfaction and Sexual Health of Female Cancer Patients in Singapore (RISE)

Breast Cancer | Gynecologic Cancer

Singapore
Millennium Pharmaceuticals, Inc.

Completed

A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas

Advanced Solid Tumors | Lymphomas

Singapore
Duke-NUS Graduate Medical School
National University Hospital, Singapore; National Cancer Centre, Singapore

Active, not recruiting

Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study (COMPASS)

Cancer

Singapore
National Cancer Centre, Singapore
Duke-NUS Graduate Medical School

Completed

Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital (SPaRK)

Cancer

Singapore

Clinical Trials on Advanced Cervical Cancer in Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations